|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
(none)
|
|
INDICATIONS:
|
|
Vasoconstriction, ophthalmic |
| |
|
|
SIDE EFFECTS:
|
|
Hyperemia, reactive |
|
Dizziness |
|
headache |
|
increased sweating |
|
nausea |
|
nervousness |
|
weakness |
|
Blurred vision |
|
large pupils |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Cardiovascular disease |
|
Diabetes mellitus |
|
Eye disease, serious, or infection or injury |
|
Hypertension |
|
Hyperthyroidism |
|
|
ADULT DOSE:
|
|
Ophthalmic decongestant-
Topical, to the conjunctiva, 1 drop of a 0.012% solution up to four times a day as needed, or 1 drop of a 0.1% solution every three to four hours as needed. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Use is not recommended.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|